CD4 and neoplasm: Another group has developed a chimeric heavy-chain antibody targeting cells expressing CTLA-4, such as Tregs and CD4 helper T cells, and reported an induction of the cytokine IFN-γ, whose pleiotropic actions include anti-tumor activity (135).